Improving the Management of Patients on Oral Regimens

Conference Correspondent - TON - ASH 2015 - Multiple Myeloma, Conference Correspondent
Beth Faiman, PhD, APRN-BC, AOCN
Editor in Chief

Beth Faiman elaborates on her idea wish list of resources and tools that would help her to better manage patients on oral oncolytics.

I often think of what my wish list would be for in a perfect world, how I would manage patients on in all oral regimen. If I could have somebody that could create calendars for may patients.

We have lots of tools that auto‑populate. But with these complex regimens, it's a challenge to get the dates right. If they miss a dose, how does that address? If I could have somebody to create a calendar or tool to help manage, that would be great.

The pharmaceutical companies and the pharmacies have staff, as I mentioned before, that help remind me to refill. Because remember these drugs are dosed, most of them at a monthly basis. At the end of each month, many of the drugs have to be refilled.

If there is a delay in dispensing on my end and a delay in dispensing on the pharmacy end, then that could put the patients off schedule. Keeping those resources available, those reminders available help me to do my job and help the patient get what they need.

Related Items
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Cancer Center Profile
Patient-Reported Outcomes Influence Radiation Guidelines
Alice Goodman
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Conference Correspondent
Healthy Lifestyle Improves Survival in Patients with Colon Cancer
Phoebe Starr
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Colorectal Cancer, Conference Correspondent
8-Week Internet-Based Psychological Intervention Reduces Stress in Patients Newly Diagnosed with Cancer
Phoebe Starr
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Conference Correspondent
Hair Loss Seen in 1 of 3 Women with Breast Cancer Receiving Endocrine Therapy
Alice Goodman
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Conference Correspondent
More Support for Regular Use of Low-Dose Aspirin
Phoebe Starr
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Conference Correspondent
Cardiotoxicity with Targeted Therapies Is Rare, but Requires Attention
Phoebe Starr
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Conference Correspondent
Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA 2017 Highlights
Maintenance Chemotherapy After Hematopoietic Stem-Cell Transplantation
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA 2017 Highlights
Graft-versus-Host Disease: Breakthroughs on the Horizon
Chase Doyle
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in Conference Correspondent, HOPA 2017 Highlights
Last modified: February 10, 2016